Jiangsu Cancer Institute & Hospital

This study tests a new approach for people with early-stage non-small-cell lung cancer that can be removed with surgery. Before surgery, participants will receive a short course of targeted radiation (SBRT) combined with an immunotherapy drug (QL1706) and chemotherapy. The goal i…

This study tests a combination of four drugs (iparomlimab, tuvonralimab, bevacizumab, and chemotherapy) as a first treatment for people with advanced colorectal cancer that cannot be surgically removed. The goal is to see if this mix can shrink tumors and delay cancer growth. Abo…

This study tests whether adding low-dose radiation and an immunotherapy drug (tislelizumab) to standard chemotherapy before surgery can improve outcomes for people with locally advanced stomach or gastroesophageal junction cancer. About 114 adults aged 20-80 with resectable tumor…

This study tests a new combination of drugs (iparomlimab, tuvonralimab, chemotherapy, and olaparib) given before surgery to shrink advanced ovarian cancer. About 50 women will receive 3 cycles of treatment, then doctors will check if the tumor has shrunk enough for surgery. The g…

This study looks for biological markers in people with nasopharyngeal carcinoma, a type of head and neck cancer. Researchers will analyze tissue samples to find patterns that may help predict how the disease will progress. The goal is to improve future treatment decisions, not to…